Effectiveness of Polymyxin B-Immobilized Fiber Column in Sepsis
Author Information
Author(s): Cruz Dinna N, Perazella Mark A, Bellomo Rinaldo, Cal Massimo, Polanco Natalia, Corradi Valentina, Lentini Paolo, Nalesso Federico, Ueno Takuya, Ranieri V Marco, Ronco Claudio
Primary Institution: Ospedale San Bortolo, Vicenza, Italy
Hypothesis
Does direct hemoperfusion with Polymyxin B-immobilized fiber improve outcomes in septic patients?
Conclusion
Direct hemoperfusion with PMX-F appears to have favorable effects on blood pressure, use of vasoactive drugs, oxygenation, and mortality.
Supporting Evidence
- Mean arterial pressure increased by 19 mm Hg after treatment.
- Dopamine/dobutamine dose decreased by 1.8 μg/kg per minute.
- PaO2/FiO2 ratio increased by 32 units.
- PMX-F therapy was associated with a lower mortality risk (risk ratio, 0.53).
Takeaway
This study found that a special treatment using Polymyxin B can help sick patients with sepsis feel better and live longer.
Methodology
A systematic review of 28 studies including randomized controlled trials and observational studies.
Potential Biases
Publication bias and lack of blinding in studies may affect results.
Limitations
Overall study quality was suboptimal, and very few studies were designed to specifically assess mortality.
Participant Demographics
Patients included were aged 39 to 78.5 years, with a range of male percentages from 20% to 85.7%.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, 15 to 22 mm Hg
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website